Skip to content
10-Q

Quarterly Report

OXYGEN THERAPY, INC.

0001493152-17-013301

← back to feed
Filed
Nov 15, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 14, 2017 19.94M sh
Operating Cash Flow Q3 2017 · Sep 30, 2017 −$326.07K
Operating Cash Flow Q3 2017 · Sep 30, 2016 −$23.33K
Stockholders Equity Q3 2017 · Sep 30, 2017 −$14.69K
Stockholders Equity Q3 2017 · Dec 31, 2016 $253.15K
Current Liabilities Q3 2017 · Sep 30, 2017 $187.93K
Current Liabilities Q3 2017 · Dec 31, 2016 $82.23K
Current Assets Q3 2017 · Sep 30, 2017 $164.31K
Current Assets Q3 2017 · Dec 31, 2016 $325.38K
Total Assets Q3 2017 · Sep 30, 2017 $173.24K
Total Assets Q3 2017 · Dec 31, 2016 $335.38K
Sga Expense Q3 2017 · Sep 30, 2017 $127.91K
Sga Expense Q3 2017 · Sep 30, 2017 $505.93K
Sga Expense Q3 2017 · Sep 30, 2016 $92.13K
Sga Expense Q3 2017 · Sep 30, 2016 $96.03K
Net Income Q3 2017 · Sep 30, 2017 −$128.12K
Net Income Q3 2017 · Sep 30, 2017 −$507.34K
Net Income Q3 2017 · Sep 30, 2017 $726.82K
Net Income Q3 2017 · Sep 30, 2016 −$95.54K
Net Income Q3 2017 · Sep 30, 2016 −$99.45K
Operating Income Q3 2017 · Sep 30, 2017 −$127.91K
Operating Income Q3 2017 · Sep 30, 2017 −$505.93K
Operating Income Q3 2017 · Sep 30, 2016 −$92.13K
Operating Income Q3 2017 · Sep 30, 2016 −$96.03K